KAZ MINL PLC/ADR (OTCMKTS:KZMYY) Downgraded to “Sell” at ValuEngine

Share on StockTwits

ValuEngine lowered shares of KAZ MINL PLC/ADR (OTCMKTS:KZMYY) from a hold rating to a sell rating in a research report report published on Wednesday, ValuEngine reports.

Several other equities research analysts have also commented on KZMYY. Credit Suisse Group upgraded KAZ MINL PLC/ADR from an underperform rating to a neutral rating in a research report on Friday, June 28th. Zacks Investment Research upgraded KAZ MINL PLC/ADR from a sell rating to a hold rating in a research report on Tuesday, August 20th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company’s stock. KAZ MINL PLC/ADR has an average rating of Hold and an average price target of $5.25.

Shares of KAZ MINL PLC/ADR stock opened at $2.91 on Wednesday. KAZ MINL PLC/ADR has a one year low of $2.28 and a one year high of $5.05. The stock’s 50-day moving average is $2.63 and its 200 day moving average is $3.40. The firm has a market cap of $2.67 billion, a price-to-earnings ratio of 4.93 and a beta of 2.51.

About KAZ MINL PLC/ADR

KAZ Minerals PLC, together with its subsidiaries, engages in mining and processing copper and other metals primarily in Kazakhstan and Kyrgyzstan. It operates through Bozshakol, Aktogay, and East Region and Bozymchak segments. The company operates the Bozshakol open pit mine in the Pavlodar region of Kazakhstan; Aktogay open pit mine located in the east of Kazakhstan; three underground mines and concentrators located in the eastern region of Kazakhstan; and the Bozymchak copper-gold open pit mine located in western Kyrgyzstan.

Recommended Story: Why Net Income is Important to Investors

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for KAZ MINL PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KAZ MINL PLC/ADR and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Organovo  Downgraded by ValuEngine
Organovo Downgraded by ValuEngine
Bank of America Raises NVIDIA  Price Target to $275.00
Bank of America Raises NVIDIA Price Target to $275.00
Stealth BioTherapeutics  Earns Buy Rating from HC Wainwright
Stealth BioTherapeutics Earns Buy Rating from HC Wainwright
Cowen Boosts Kulicke and Soffa Industries  Price Target to $25.00
Cowen Boosts Kulicke and Soffa Industries Price Target to $25.00
Zacks Investment Research Upgrades Cannae  to “Buy”
Zacks Investment Research Upgrades Cannae to “Buy”
Bruker  Earns Hold Rating from Analysts at Stifel Nicolaus
Bruker Earns Hold Rating from Analysts at Stifel Nicolaus


 
© 2006-2019 Zolmax.